CAP TODAY Pathology/Laboratory Medicine/Laboratory Management
March 2016—ArcherDX, in partnership with Horizon Discovery Group, launched the Archer SureShot ALK, RET, ROS1 Fusion Control to benchmark greater confidence in gene fusion detection using Archer FusionPlex Panels. The reference control is composed of FFPE curls of homogeneously mixed, precisely defined cell lines that contain EML4-ALK, CCDC6-RET, and SLC34A2-ROS1 fusions.
SureShot Negative Controls are also available and contain 100 percent wild-type cells that carry no target-gene fusion.
ArcherDX, 303-357-9001
Horizon, +44 (0) 1223 655 580